Conover C, Yarrow J, Garrett T, Ye F, Quinlivan E, Cannady D
J Am Med Dir Assoc. 2017; 18(4):366.e17-366.e24.
PMID: 28214238
PMC: 8349505.
DOI: 10.1016/j.jamda.2016.12.077.
Nagy H, Chapurlat R, Sornay-Rendu E, Boutroy S, Szulc P
Osteoporos Int. 2014; 26(3):921-30.
PMID: 25524020
DOI: 10.1007/s00198-014-2974-0.
Kumar A, Shekhar S, Dhole B
Indian J Endocrinol Metab. 2014; 18(1):23-31.
PMID: 24701426
PMC: 3968728.
DOI: 10.4103/2230-8210.126523.
Rock C, Pande C, Flatt S, Ying C, Pakiz B, Parker B
Clin Breast Cancer. 2013; 13(3):188-95.
PMID: 23375717
PMC: 4153749.
DOI: 10.1016/j.clbc.2012.12.002.
Morris P, Channer K
Asian J Androl. 2012; 14(3):428-35.
PMID: 22522504
PMC: 3720171.
DOI: 10.1038/aja.2012.21.
Circulating brain-derived neurotrophic factor and indices of metabolic and cardiovascular health: data from the Baltimore Longitudinal Study of Aging.
Golden E, Emiliano A, Maudsley S, Windham B, Carlson O, Egan J
PLoS One. 2010; 5(4):e10099.
PMID: 20404913
PMC: 2852401.
DOI: 10.1371/journal.pone.0010099.
Extremes of endogenous testosterone are associated with increased risk of incident coronary events in older women.
Laughlin G, Goodell V, Barrett-Connor E
J Clin Endocrinol Metab. 2009; 95(2):740-7.
PMID: 19934360
PMC: 2840853.
DOI: 10.1210/jc.2009-1693.
Early detection of prostate cancer local recurrence by urinary prostate-specific antigen.
Bolduc S, Inman B, Lacombe L, Fradet Y, Tremblay R
Can Urol Assoc J. 2009; 3(3):213-7.
PMID: 19543465
PMC: 2692171.
DOI: 10.5489/cuaj.1074.
Endogenous oestrogens predict 4-year decline in verbal fluency in postmenopausal women: the Rancho Bernardo Study.
Laughlin G, Kritz-Silverstein D, Barrett-Connor E
Clin Endocrinol (Oxf). 2009; 72(1):99-106.
PMID: 19508596
PMC: 2805055.
DOI: 10.1111/j.1365-2265.2009.03599.x.
Statin therapy is associated with lower total but not bioavailable or free testosterone in men with type 2 diabetes.
Stanworth R, Kapoor D, Channer K, Jones T
Diabetes Care. 2008; 32(4):541-6.
PMID: 19114614
PMC: 2660443.
DOI: 10.2337/dc08-1183.
Relations between endogenous androgens and estrogens in postmenopausal women with suspected ischemic heart disease.
Braunstein G, Johnson B, Stanczyk F, Bittner V, Berga S, Shaw L
J Clin Endocrinol Metab. 2008; 93(11):4268-75.
PMID: 18728170
PMC: 2582570.
DOI: 10.1210/jc.2008-0792.
Urinary PSA: a potential useful marker when serum PSA is between 2.5 ng/mL and 10 ng/mL.
Bolduc S, Lacombe L, Naud A, Gregoire M, Fradet Y, Tremblay R
Can Urol Assoc J. 2008; 1(4):377-81.
PMID: 18542821
PMC: 2422995.
DOI: 10.5489/cuaj.444.
Testosterone for the aging male; current evidence and recommended practice.
Stanworth R, Jones T
Clin Interv Aging. 2008; 3(1):25-44.
PMID: 18488876
PMC: 2544367.
DOI: 10.2147/cia.s190.
Abdominal aortic calcification, BMD, and bone microstructure: a population-based study.
Chow J, Khosla S, Melton 3rd L, Atkinson E, Camp J, Kearns A
J Bone Miner Res. 2008; 23(10):1601-12.
PMID: 18466072
PMC: 2605688.
DOI: 10.1359/jbmr.080504.
Comparison of sex steroid measurements in men by immunoassay versus mass spectroscopy and relationships with cortical and trabecular volumetric bone mineral density.
Khosla S, Amin S, Singh R, Atkinson E, Melton 3rd L, Riggs B
Osteoporos Int. 2008; 19(10):1465-71.
PMID: 18338096
PMC: 2636568.
DOI: 10.1007/s00198-008-0591-5.
Hyperandrogenism and hyperinsulinism in children of women with polycystic ovary syndrome: a controlled study.
Kent S, Gnatuk C, Kunselman A, Demers L, Lee P, Legro R
J Clin Endocrinol Metab. 2008; 93(5):1662-9.
PMID: 18270257
PMC: 2386683.
DOI: 10.1210/jc.2007-1958.
Low serum testosterone and mortality in older men.
Laughlin G, Barrett-Connor E, Bergstrom J
J Clin Endocrinol Metab. 2007; 93(1):68-75.
PMID: 17911176
PMC: 2190742.
DOI: 10.1210/jc.2007-1792.
Searching for polycystic ovary syndrome in postmenopausal women: evidence of a dose-effect association with prevalent cardiovascular disease.
Krentz A, von Muhlen D, Barrett-Connor E
Menopause. 2007; 14(2):284-92.
PMID: 17245231
PMC: 2642654.
DOI: 10.1097/GME.0b013e31802cc7ab.
Diagnostic criteria for polycystic ovarian syndrome.
Broekmans F, Fauser B
Endocrine. 2006; 30(1):3-11.
PMID: 17185786
DOI: 10.1385/ENDO:30:1:3.
Study protocol to investigate the effects of testosterone therapy as an adjunct to exercise rehabilitation in hypogonadal males with chronic heart failure.
Saxton J, Zwierska I, Mathur A, Channer K
BMC Cardiovasc Disord. 2006; 6:46.
PMID: 17137495
PMC: 1693568.
DOI: 10.1186/1471-2261-6-46.
